Stay updated on Pegcetacoplan in C3 Glomerulopathy: Clinical Trial

Sign up to get notified when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now displays the VALIANT Phase 3 clinical trial record, including its study design, eligibility criteria, outcomes, publications, and study documents.
    Difference
    100%
    Check dated 2026-11-07T15:11:14.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T15:37:20.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A notice was added announcing NIH website updates and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition. It appears above the study record, which remains inaccessible.
    Difference
    1%
    Check dated 2026-10-24T15:59:13.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T15:50:24.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1; the 403 error page otherwise remains unchanged.
    Difference
    0.2%
    Check dated 2026-10-10T15:44:54.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study content and navigation. This makes the study record inaccessible until the error is resolved.
    Difference
    17%
    Check dated 2026-09-19T18:58:27.000Z thumbnail image

Stay in the know with updates to Pegcetacoplan in C3 Glomerulopathy: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pegcetacoplan in C3 Glomerulopathy: Clinical Trial page.